1. South Korea Stocks

  2. •

    Consumer non-durables

  3. •

    Household/Personal care
Coreana Cosmetics Co., Ltd

Coreana Cosmetics Co., Ltd

KKRX:027050
1,200.00
KRW
-18.00
(-1.48%)
-226.60EPS
56.70BMarket Cap
Coreana Cosmetics Co., Ltd
KRX:027050
(Korea Stock Exchange)

Recent

price

1,200.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
3,376.57
3,385.82
3,132.16
3,173.25
3,232.42
4,332.84
3,906.6
3,565.05
3,738.93
3,758.53
2,797.45
2,802.89
2,598.29
2,790.25
2,708.96
2,369.1
2,299.51
Revenue per Share
-84
20.2
360
9
-183
198
129
58
56
19
-16
107
49
58
27
-249
-226.91
Basic EPS, GAAP
-10.31
380.24
-233.23
-428.23
-139
-163.41
6.49
113.4
7.33
143.95
-13.74
255.1
162.25
34.75
0.85
-58.34
-87.85
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
50.01
50.66
50.08
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
1,573.34
1,989.75
2,336.22
2,334.03
2,121.52
2,501.72
2,562
2,510.75
2,520.21
2,520.44
2,532.85
2,695.51
2,724.98
2,825.45
2,857.8
2,600.33
2,629.26
Book Value per Share
1,469.44
1,884.83
2,239.69
2,253.67
2,034.62
2,427.54
2,487.78
2,423.69
2,426.27
2,415.83
2,429.22
2,595.77
2,642.39
2,752.24
2,794.43
2,545.01
2,574.04
Tangible Book Value per Share
31
31
31
30
31
32
32
31
31
31
31
31
31
31
30
31
32
Basic Weighted Avg Shares
105,147
105,626
97,726
95,706
101,114
136,517
124,020
111,709
115,728
117,202
86,658
87,050
80,394
86,049
82,452
73,677
73,223
Sales/Revenue/Turnover
0.47
-3.62
-1.49
-1.08
-4.97
4.7
3.23
1.95
1.77
2.72
-0.95
3.98
1.1
1.11
0.54
-5.91
-5.28
Operating Margin (%)
3,750
3,904
3,520
3,310
3,645
3,563
3,485
4,031
4,132
6,323
5,499
4,906
4,444
3,887
3,221
2,716
2,572
Depreciation Expense
-2,616
630
11,232
271
-5,724
6,239
4,095
1,817
1,733
592
-496
3,323
1,516
1,789
822
-7,744
-7,226
Net Income, GAAP
- -
- -
18.48
3.36
- -
10.72
4.74
6.94
27.03
84.62
- -
23.87
3.27
14.53
44.79
- -
- -
Effective Tax Rate (%)
-2.49
0.6
11.49
0.28
-5.66
4.57
3.3
1.63
1.5
0.51
-0.57
3.82
1.89
2.08
1
-10.51
-9.87
Profit Margin (%)
-8,510
9,584
18,148
11,833
7,561
16,435
16,485
11,741
11,926
13,368
11,138
19,453
21,498
19,535
21,188
23,493
24,250
Working Capital
- -
- -
- -
5,839
8,167
6,499
4,999
3,999
5,899
7,350
1,708
600
1,533
1,359
733
300
358
LT Debt
49,083
61,744
72,556
72,481
65,950
79,087
80,968
77,413
77,632
77,548
77,905
82,932
82,748
85,804
86,323
83,731
84,662
Total Equity
- -
- -
-1.59
-1.23
- -
6.28
4.09
2.18
1.6
0.5
- -
2.85
0.95
0.89
0.26
- -
- -
Return on Invested Capital (%)
- -
- -
15.27
0.73
- -
7.7
5.02
2.56
2.41
0.83
- -
3.89
1.96
2.39
1.16
- -
- -
Return on Capital (%)
-5.09
1.13
16.65
0.37
-8.24
8.57
5.09
2.28
2.22
0.76
-0.63
4.1
1.82
2.11
0.95
-9.07
-8.46
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1,515
1,299
1,245
LT Borrowings
- -
- -
- -
LT Finance Leases
599
300
358
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
32
32
32
Market Capitalization
90,643
74,382
56,704

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
36,067
34,123
36,333
Cash, Cash Equivalents & STI
11,509
10,695
11,699
Accounts Receivable, Net
6,190
5,706
6,357
Inventories
15,326
15,296
15,141
Total Current Liabilities
11,672
10,629
12,083
Payables & Accruals
- -
- -
- -
ST Debt
1,515
1,299
1,245
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.61%
1.5%
-3%
Free Cash Flow
-609.48%
-1,858.31%
-7,117.22%
Net Income, GAAP
-224.73%
-380.65%
-1,042.3%
Sales/Revenue/Turnover
-5.53%
-3%
-10.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
21,132
21,528
19,648
20,143
82,452
2025
19,071
20,506
16,812
17,289
73,677
2026
18,616
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.59
9
9
9.54
27
2025
-10
19.96
-79.34
-169.12
-249
2026
6.69
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Procter & Gamble Company (The) (NYSE:PG)
Cupid Limited (NSE:CUPID)
Hindustan Unilever Limited (NSE:HINDUNILVR)
Colgate-Palmolive (India) Limited (NSE:COLPAL)
Dabur India Limited (NSE:DABUR)
e.l.f. Beauty, Inc. (NYSE:ELF)
Business
Coreana Cosmetics Co., Ltd. is a South Korea-based company primarily engaged in the research, development, manufacturing, and distribution of skincare, makeup, and personal care cosmetics, as well as the provision of original design manufacturing (ODM) and original equipment manufacturing (OEM) services. Founded in 1988 and headquartered in Cheonan, Chungcheongnam-do, South Korea, with corporate offices in Suwon, Gyeonggi-do, the company operates across prestige, mass-market, and functional derma-cosmetic segments. The company's product and service offerings comprise: basic and functional skincare, including anti-aging serums, peptide ampoules, barrier repair creams, hydrating toners, essences, and emulsions; traditional herbal cosmetics, formulated with fermented botanical extracts and oriental medicinal ingredients; derma-cosmetics and specialized dermatological treatments; color cosmetics and makeup products, including foundations, BB creams, cushions, lipsticks, and eye makeup; sun care, hair care, and body care items; professional aesthetic salon care solutions; and turnkey OEM/ODM contract manufacturing services, providing custom formulation research, stability testing, packaging design, and CGMP-certified production for domestic and international beauty brands. Coreana commercializes its products under a portfolio of proprietary brands, including LAVIDA, AMPLE:N, Zain, Senite, Nokdu, Cellenique, Preange, Bichugain, Entia, Ten Seconds, and Orthia. The company conducts business in South Korea and across global markets, including China—supported by its manufacturing subsidiary Coreana Cosmetics (Tianjin) Co., Ltd.—as well as Southeast Asia, North America, Europe, and Latin America, utilizing multi-channel distribution through retail beauty stores, department stores, aesthetic franchise centers, home shopping networks, and cross-border e-commerce platforms. In recent developments, Coreana Cosmetics has strategically expanded its OEM/ODM contract manufacturing operations to serve growing global demand from emerging indie beauty labels, leveraging expanded CGMP-compliant production capacities at its Cheonan plant. The company has also accelerated its geographic diversification strategy beyond East Asia, expanding sales channels into the Americas and European e-commerce markets, while launching refreshed formulations and patented bioactive peptide treatments under its flagship AMPLE:N derma-skincare brand through its dedicated Songpa Institute of Technology research center.